Diabetes, Obesity and COVID-19 Webinar, 18:00-19:30, 25 June 2020.
We invite you to join a host of expert speakers and panelists this Thursday evening for our webinar addressing the important and relevant topic of COVID-19 and its links with diabetes and obesity. The 1.5 hour webinar will provide you with detail on those links and predispositions, as well discussion around clinical challenges and considerations relating to the pandemic.
Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fully fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO.